Barely Significant
← all excerpts

Endostatin and Oxaliplatin-Based Chemoradiotherapy for Inoperable Esophageal Squamous Cell Carcinoma: Results of a Phase II Study.

Oncologist · 2019 · PMC6459259 · PMID 30850562

Europe PMCDOI
1
hedged sentence
0.0660
closest p · 1.3× alpha
0.0660
boldest claim

The sentences

marginally significantp = .066so close (0.05 < p ≤ 0.1)
Although survival analysis indicated no significant difference between the FOLFOX group and the 5‐FU and cisplatin group, the FOLFOX regimen was associated with a marginally significant reduction of treatment‐related death compared with the 5‐FU and cisplatin regimen (1 vs. 6; p = .066).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.